Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg

NCT01893840 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-10-31

No results posted yet for this study

Summary

A study to assess the effect of negative pulsating pressure therapy on patients with impaired blood flow to the leg caused by arterial disease, to see if the FlowOx device will increase the blood flow to the leg in these patients.

Conditions

  • Periferal Arterial Occlusive Disease, PAOD

Interventions

DEVICE

FlowOx

Boot-shaped pressure chamber generating pulsating negative pressure

Sponsors & Collaborators

  • European Union

    collaborator OTHER
  • The Research Council of Norway

    collaborator OTHER
  • Otivio AS

    lead INDUSTRY

Principal Investigators

  • Jarlis Wesche, PhD · Principal Investigator

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Norway

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01893840 on ClinicalTrials.gov